New hope for toughest leukemia cases: white blood cell boost added to transplant
NCT ID NCT07372885
Summary
This trial is testing a new type of stem cell transplant for young adults (under 55) with a very high-risk form of acute myeloid leukemia (AML) that hasn't responded well to standard chemotherapy. The treatment uses umbilical cord blood stem cells and adds extra infusions of a type of white blood cell called granulocytes, based on promising results seen in children. The study will first check if this approach is safe for adults and then see if it works better than a standard transplant at preventing the cancer from coming back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kings College Hospital NHS Trust
London, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Christie NHS Foundation Trust
Manchester, United Kingdom
Contact Email: •••••@•••••
Contact
-
The Royal Marsden Hospital NHS Foundation Trust
London, United Kingdom
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.